← brief for 2026-09-30 · Slowing decline

SGLT2 inhibitors as a strategy for volume management in peritoneal dialysis: a case series

Key takeaways

This study looked at seven people on peritoneal dialysis who took a drug called an SGLT2 inhibitor. The researchers tracked how much fluid the patients removed from their bodies. In four patients who started the drug, three removed more fluid and one removed less. This small group of seven people shows a link, but it is not proof that the drug always works this way.

Who did this work

R. Haridian Sosa Barrios (Universidad de Alcalá) · Miriam Domínguez-Tejedor (Instituto Ramón y Cajal de Investigación Sanitaria) · Raquel Moreno Garcia (Hospital Universitario Ramón y Cajal) · Víctor Burguera Vion (Instituto Ramón y Cajal de Investigación Sanitaria) · Milagros Fernández Lucas (Universidad de Alcalá) · Maite E. Rivera Gorrín (Universidad de Alcalá)

Source

Article · OpenAlex, CKD works · 2026-09-29
https://doi.org/10.3389/fneph.2026.1942462